XEOMIN (zee-oh-min) is a treatment option for adults with upper limb spasticity, cervical dystonia, and blepharospasm.
State-of-the-art proprietary manufacturing process purifies botulinum toxin A into XEOMIN1
The active ingredient in XEOMIN is a type of botulinum toxin called incobotulinumtoxinA. Merz, the maker of XEOMIN, uses a proprietary purification process to remove accessory proteins from botulinum toxin A to make XEOMIN.1 The clinical significance of a lack of accessory proteins, including any impact on safety or efficacy, has not been established.
XEOMIN® is a prescription medicine that is injected into muscles and used to treat:1
- increased muscle stiffness in the arm of adults with upper limb spasticity
- abnormal head position and neck pain in adults with cervical dystonia (CD)
- abnormal spasm of the eyelids (blepharospasm) in adults who have had prior treatment with onabotulinumtoxinA (BOTOX®)
The potency units of Xeomin are not interchangeable with other botulinum toxin products.1
- XEOMIN® [package insert]. Raleigh, NC: Merz North America, Inc; 2015.
XEOMIN is a registered trademark of Merz Pharma GmbH & Co. KGaA.
Botox® is a registered trademark of Allergan, Inc.
Dysport® is a registered trademark of Ipsen Biopharm Limited.
Myobloc® is a registered trademark of Solstice Neurosciences, Inc.